Recombinant Escherichia coli Glucokinase (glk)

Shipped with Ice Packs
In Stock

Description

Definition and Biological Role

Recombinant Escherichia coli glucokinase (Glk) is a genetically engineered enzyme produced by cloning and expressing the glk gene in E. coli. This ATP-dependent enzyme catalyzes the phosphorylation of glucose to glucose-6-phosphate (G6P), a critical step in glycolysis and carbohydrate metabolism . Unlike glucose uptake via the phosphoenolpyruvate-dependent phosphotransferase system (PTS), Glk phosphorylates intracellular glucose derived from disaccharide hydrolysis (e.g., lactose, maltose) .

Key Properties of Recombinant Glk

PropertyValue/DescriptionSource
Gene locusb2388 (JW2385)
Molecular weight37.1 kDa (including His-tag)
Substrate specificityGlucose (Km = 0.78 mM), ATP (Km = 3.76 mM)
Optimal pH9.0

Kinetic Parameters

ParameterValueConditionsSource
KmK_m (glucose)0.78 mM5 mM ATP, pH 9.0, 37°C
KmK_m (ATP)3.76 mM5 mM glucose, pH 9.0, 37°C
VmaxV_{max}158 U/mgpH 9.0, 37°C

Metabolic Pathways

  • Glucose phosphorylation: Critical for metabolizing internal glucose from disaccharides (e.g., maltose, trehalose) when PTS is inactive .

  • Energy conservation: Overexpression in evolved E. coli strains enhances ATP yield by bypassing PTS-dependent glucose uptake .

Regulatory Interactions

  • Carbon catabolite repression: Glk expression is reduced by 50% during growth on glucose .

  • FruR regulation: A FruR-binding motif upstream of glk modulates transcription, with fruR mutations increasing glk expression .

Metabolic Engineering

  • Succinate production: Evolved E. coli strains use Glk with GalP permease to increase PEP availability, improving succinate yields .

  • Nitrogen-limited fermentation: Glk overexpression mitigates metabolic slowdown under nitrogen stress .

Protein Production

  • Expression system: Recombinant Glk is produced in E. coli with >95% purity via nickel-chelate chromatography .

  • Stability: Retains activity in 20 mM Tris-HCl (pH 8.0), 0.15 M NaCl, and 10% glycerol at -20°C .

Production and Purification Protocol

StepDetailsSource
Cloningglk inserted into pQE30 vector (Sma I site)
Expression hostE. coli DH5α or BL21
Induction1 mM IPTG
PurificationNi²⁺ affinity chromatography
Purity verificationSDS-PAGE (>95%)

Comparative Analysis with Homologs

OrganismIdentity (%)Key DifferencesSource
Brucella abortus38%Higher thermostability
Staphylococcus aureus15%Lacks ROK motif; ATP-independent
Human hexokinase16–18%Larger size (100 kDa); broader substrate

Challenges and Limitations

  • Redundant function: Native PTS minimizes Glk’s role in glucose metabolism unless pts genes are deleted .

  • Overexpression toxicity: High Glk levels repress maltose transport via competition for intracellular glucose .

Future Directions

  • Bioreactor optimization: Tuning glk expression to balance ATP yield and metabolic burden .

  • Structural engineering: Modifying substrate specificity for non-natural sugars .

Product Specs

Form
Lyophilized powder. We will ship the available format, but you can request a specific format when ordering.
Lead Time
Delivery times vary. Contact your local distributor for details. Proteins are shipped with blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
glk; EcSMS35_2540Glucokinase; EC 2.7.1.2; Glucose kinase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-321
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli (strain SMS-3-5 / SECEC)
Target Names
glk
Target Protein Sequence
MTKYALVGDV GGTNARLALC DIASGEISQA KTYSGLDYPS LEAVIRVYLE EHKVEVKDGC IAIACPITGD WVAMTNHTWA FSIAEMKKNL GFSYLEIIND FTAVSMAIPM LKKEHLIQFG GAEPVEGKPI AVYGAGTGLG VAHLVHVDKR WVSLPGEGGH VDFAPNSEEE GIILEILRAE IGHVSAERVL SGPGLVNLYR AIVKADNRLP ENLKPKDITE RALADSCTDC RRALSLFCVI MGRFGGNLAL NLGTFGGVFI AGGIVPRFLE FFKASGFRAA FEDKGRFKEY VHDIPVYLIV HDNPGLLGSG AHLRQTLGHI L
Uniprot No.

Target Background

Database Links
Protein Families
Bacterial glucokinase family
Subcellular Location
Cytoplasm.

Q&A

What is the functional role of recombinant E. coli glucokinase in metabolic studies, and how does it differ from native glucokinase?

Recombinant E. coli glucokinase (glk) is an ATP-dependent kinase that phosphorylates glucose to glucose-6-phosphate (G6P), bypassing the phosphotransferase system (PTS) used for glucose uptake in wild-type strains . While native glucokinase plays a minor role in E. coli metabolism due to PTS dominance, recombinant versions enable controlled studies of glucose metabolism, bypassing PTS limitations. This is critical for analyzing G6P production in glycolysis, catabolite repression, or engineered metabolic pathways.

Methodological Note: Recombinant glucokinase is expressed in E. coli with high purity (>95%) and is validated for SDS-PAGE, mass spectrometry (MS), and functional assays . Researchers often use it to:

  • Study glucose metabolism in glk-deficient mutants.

  • Assess enzyme kinetics (e.g., Km for glucose = 0.78 mM, Vmax = 158 U/mg) .

  • Examine catabolite repression mechanisms, as overexpression of glk represses maltose system expression .

How do the kinetic parameters of glucokinase influence experimental design?

The kinetic profile of glucokinase (Km = 0.78 mM for glucose, Km = 3.76 mM for ATP, Vmax = 158 U/mg) dictates substrate concentrations and reaction conditions .

ParameterValueExperimental Implication
Km (glucose)0.78 mMUse glucose concentrations ≥1 mM to saturate enzyme.
Vmax158 U/mgOptimize reaction time based on protein quantity.
Substrate SpecificityGlucose onlyAvoid cross-reactivity with fructose/galactose.

Advanced Consideration: Kinetic studies should account for ATP depletion in reactions. Use ATP-regenerating systems (e.g., phosphoenolpyruvate/pyruvate kinase) to maintain steady-state conditions for accurate Vmax measurements.

What methods are effective for assessing glucokinase activity in vitro?

Activity can be quantified via:

  • ATP-Dependent Phosphorylation Assays:

    • Measure G6P production using NADH-linked assays (e.g., hexokinase/glucose-6-phosphate dehydrogenase coupling).

    • Validate with HPLC or MS to confirm product identity .

  • SDS-PAGE and Western Blotting:

    • Confirm protein purity and identity (35 kDa band) .

  • Enzyme Kinetics:

    • Use fluorometric or spectrophotometric methods to determine Km and Vmax .

Data Table:

MethodAdvantagesLimitations
NADH-Linked AssaysHigh sensitivity, real-time kineticsRequires coupled enzymes.
HPLC/MSConfirmatory product analysisLow throughput, high cost.
SDS-PAGERapid purity assessmentNo activity data.

Why is glk expression downregulated in the presence of glucose in E. coli?

Glucose represses glk expression by ~50% through mechanisms involving FruR, a transcriptional regulator . A FruR binding motif is located 123 bp upstream of the glk promoter, suggesting direct regulation . Overexpression of FruR+ weakly decreases glk expression, while fruR mutations increase it. This repression ensures metabolic efficiency: glucose-6-phosphate from the PTS system is prioritized over glucokinase activity.

Experimental Design Tip: To study glk regulation, use glk-lacZ fusions to monitor expression under varying carbon sources. Include controls with fruR mutants to isolate regulatory effects.

What factors influence the recruitment of alternative kinases in glucokinase-deficient E. coli strains?

Adaptive evolution experiments reveal that enzyme recruitment depends on trade-offs between catalytic efficiency and substrate specificity . For example, N-acetylmannosamine kinase (NanK) was preferentially recruited over N-acetylglucosamine kinase (NagK) or N-acetylmannosamine kinase (NanK), despite NagK having higher catalytic efficiency (kcat/Km = 2,400 M⁻¹s⁻¹ vs. NanK: ~15 M⁻¹s⁻¹) . Key factors include:

  • Metabolic Flux: NanK mutations enhanced glucokinase activity but reduced its native N-acetylmannosamine kinase activity, causing a trade-off in fitness.

  • Transcriptional Amplification: Early mutations increased nanK transcription, amplifying NanK levels to compensate for low activity.

Data Table:

KinaseCatalytic Efficiency (kcat/Km)Recruitment Status
NagK2,400 M⁻¹s⁻¹Not recruited
Mak200 M⁻¹s⁻¹Not recruited
NanK~15 M⁻¹s⁻¹Recruited
AlsK15 M⁻¹s⁻¹Not recruited

How to optimize recombinant glucokinase expression for functional studies?

To maximize expression and activity:

  • Strain Selection: Use E. coli strains lacking native glucokinase (e.g., glk knockout) to avoid competition.

  • Induction Conditions:

    • Grow at 30–37°C using T7-based expression systems (e.g., BL21(DE3)).

    • Optimize IPTG concentration (0.1–1 mM) to balance yield and solubility.

  • Purification:

    • Use Ni-NTA affinity chromatography for His-tagged variants.

    • Validate purity via SDS-PAGE and MS .

Advanced Strategy: Co-express molecular chaperones (e.g., GroES-GroEL) to improve protein folding.

What are the implications of using active vs. non-active recombinant glucokinase in experiments?

Active recombinant glucokinase (e.g., Abcam ab208303) retains full enzymatic function, enabling studies of glucose phosphorylation kinetics and metabolic engineering applications . Non-active versions (e.g., ab183231) may lack cofactor binding or catalytic residues but are suitable for structural studies (e.g., crystallization).

Methodological Comparison:

PropertyActive (ab208303)Non-Active (ab183231)
ATP BindingYesNo/Partial
G6P ProductionYesNo
Suitable ForKinetic assaysStructural studies
Handling PrecautionsBiohazard containmentStandard

How to reconcile in vitro activity of recombinant glucokinase with its limited in vivo role in E. coli metabolism?

In vitro, recombinant glucokinase exhibits high activity due to optimized conditions (e.g., excess ATP, absence of competing pathways) . In vivo, the PTS system dominates glucose uptake, rendering glucokinase redundant unless engineered for specific metabolic tasks.

Experimental Controls:

  • Compare Activity in glk-Deficient Strains:

    • Measure G6P levels in strains expressing glucokinase vs. wild-type.

  • Monitor Metabolic Flux:

    • Use isotopic labeling (e.g., ¹³C-glucose) to track G6P production in engineered pathways.

What are the key challenges in using glucokinase for metabolic engineering in E. coli?

  • Substrate Competition: Glucokinase competes with PTS for glucose, requiring precise regulation.

  • Catabolite Repression: Overexpression represses maltose system genes, complicating co-expression with other sugar utilization pathways .

  • Evolutionary Trade-offs: Recruiting alternative kinases (e.g., NanK) reduces fitness on native substrates .

Mitigation Strategies:

  • Engineer strains with constitutive glk expression and pts-deficient mutations.

  • Use synthetic promoters to decouple glk expression from endogenous regulators.

How does glucokinase interact with other metabolic pathways in E. coli?

Glucokinase activity impacts:

  • Glycolytic Flux: G6P feeds into glycolysis, bypassing PTS-regulated entry points.

  • Catabolite Repression: High G6P levels inhibit the maltose system via MalK-dependent mechanisms .

  • Redox Balance: ATP consumption in glucokinase reactions may alter NAD+/NADH ratios.

Experimental Design: Co-monitor G6P, ATP, and NADH levels to map metabolic interactions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.